A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy

被引:116
作者
Kaminski, Michal F. [1 ,2 ]
Polkowski, Marcin [1 ,2 ]
Kraszewska, Ewa [2 ]
Rupinski, Maciej [1 ,2 ]
Butruk, Eugeniusz [3 ]
Regula, Jaroslaw [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Gastroenterol Oncol, Warsaw, Poland
[2] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland
[3] Polish Fdn Gastroenterol, Warsaw, Poland
关键词
FECAL IMMUNOCHEMICAL TEST; CANCER SCREENING TRIALS; AVERAGE-RISK; DIAGNOSTIC PERFORMANCE; FLEXIBLE SIGMOIDOSCOPY; PREDICTION MODEL; FAMILY-HISTORY; POPULATION; METAANALYSIS; PREVENTION;
D O I
10.1136/gutjnl-2013-304965
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective This study aimed to develop and validate a model to estimate the likelihood of detecting advanced colorectal neoplasia in Caucasian patients. Design We performed a cross-sectional analysis of database records for 40-year-old to 66-year-old patients who entered a national primary colonoscopy-based screening programme for colorectal cancer in 73 centres in Poland in the year 2007. We used multivariate logistic regression to investigate the associations between clinical variables and the presence of advanced neoplasia in a randomly selected test set, and confirmed the associations in a validation set. We used model coefficients to develop a risk score for detection of advanced colorectal neoplasia. Results Advanced colorectal neoplasia was detected in 2544 of the 35 918 included participants (7.1%). In the test set, a logistic-regression model showed that independent risk factors for advanced colorectal neoplasia were: age, sex, family history of colorectal cancer, cigarette smoking (p<0.001 for these four factors), and Body Mass Index (p=0.033). In the validation set, the model was well calibrated (ratio of expected to observed risk of advanced neoplasia: 1.00 (95% CI 0.95 to 1.06)) and had moderate discriminatory power (c-statistic 0.62). We developed a score that estimated the likelihood of detecting advanced neoplasia in the validation set, from 1.32% for patients scoring 0, to 19.12% for patients scoring 7-8. Conclusions Developed and internally validated score consisting of simple clinical factors successfully estimates the likelihood of detecting advanced colorectal neoplasia in asymptomatic Caucasian patients. Once externally validated, it may be useful for counselling or designing primary prevention studies.
引用
收藏
页码:1112 / 1119
页数:8
相关论文
共 49 条
  • [1] Use of colonoscopy as a primary screening test for colorectal cancer in average risk people
    Betés, M
    Muñoz-Navas, MA
    Duque, JM
    Angós, R
    Macías, E
    Súbtil, JC
    Herraiz, M
    De La Riva, S
    Delgado-Rodríguez, M
    Martínez-González, MA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12) : 2648 - 2654
  • [2] Cigarette smoking and adenomatous polyps: A meta-analysis
    Botteri, Edoardo
    Iodice, Simona
    Raimondi, Sara
    Maisonneuve, Patrick
    Lowenfels, Albert B.
    [J]. GASTROENTEROLOGY, 2008, 134 (02) : 388 - 395
  • [3] Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy
    Brenner, Hermann
    Tao, Sha
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 3049 - 3054
  • [4] Derivation and Validation of a Prediction Rule for Estimating Advanced Colorectal Neoplasm Risk in Average-Risk Chinese
    Cai, Quan-Cai
    Yu, En-Da
    Xiao, Yi
    Bai, Wen-Yuan
    Chen, Xing
    He, Li-Ping
    Yang, Yu-Xiu
    Zhou, Ping-Hong
    Jiang, Xue-Liang
    Xu, Hui-Min
    Fan, Hong
    Ge, Zhi-Zheng
    Lv, Nong-Hua
    Huang, Zhi-Gang
    Li, You-Ming
    Ma, Shu-Ren
    Chen, Jie
    Li, Yan-Qing
    Xu, Jian-Ming
    Xiang, Ping
    Yang, Li
    Lin, Fu-Lin
    Li, Zhao-Shen
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 (06) : 584 - 593
  • [5] Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
    Cole, Bernard F.
    Logan, Richard F.
    Halabi, Susan
    Benamouzig, Robert
    Sandler, Robert S.
    Grainge, Matthew J.
    Chaussade, Stanislas
    Baron, John A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04): : 256 - 266
  • [6] Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial
    Cuzick, Jack
    Cafferty, Fay H.
    Edwards, Robert
    Moller, Henrik
    Duffy, Stephen W.
    [J]. JOURNAL OF MEDICAL SCREENING, 2007, 14 (04) : 178 - 185
  • [7] Reaching targets in the national cervical screening programme: are current practices unethical?
    Foster, P
    Anderson, CM
    [J]. JOURNAL OF MEDICAL ETHICS, 1998, 24 (03) : 151 - 157
  • [8] Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility
    Freedman, Andrew N.
    Slattery, Martha L.
    Ballard-Barbash, Rachel
    Willis, Gordon
    Cann, Bette J.
    Pee, David
    Gail, Mitchell H.
    Pfeiffer, Ruth M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 686 - 693
  • [9] On criteria for evaluating models of absolute risks
    Gail, MH
    Pfeiffer, RM
    [J]. BIOSTATISTICS, 2005, 6 (02) : 227 - 239
  • [10] THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE
    HANLEY, JA
    MCNEIL, BJ
    [J]. RADIOLOGY, 1982, 143 (01) : 29 - 36